| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 11/13/2024 | $5.00 → $3.50 | Buy → Neutral | ROTH MKM |
SOMERSET, N.J., April 17, 2025 (GLOBE NEWSWIRE) -- CareCloud, Inc. (NASDAQ:CCLD, CCLDO)), a leader in healthcare technology and generative AI solutions for medical practices and health systems nationwide, will release its financial results for the first quarter ended March 31, 2025 before the market opens on Tuesday, May 6, 2025. The Company will follow with a conference call for investors at 8:30 a.m. Eastern Time. The live webcast of the conference call and related presentation slides can be accessed at ir.carecloud.com/events. An audio-only option is available by dialing 201-389-0920 and referencing "CareCloud First Quarter 2025 Results Conference Call." Investors who opt for audio-onl
SOMERSET, N.J., March 14, 2025 (GLOBE NEWSWIRE) -- CareCloud, Inc. (the "Company") (NASDAQ:CCLD, CCLDO, CCLDP)), a leader in healthcare technology and generative AI solutions for medical practices and health systems nationwide, announced today that its Board of Directors (the "Board") has declared monthly cash dividends for its 8.75% Series A Cumulative Redeemable Perpetual Preferred Stock ("Series A Preferred Stock") and its 8.75% Series B Cumulative Redeemable Perpetual Preferred Stock ("Series B Preferred Stock") for March and April 2025. The following table shows the monthly dividends and associated record and payment dates: March 2025 April 2025 Series A dividend per share $0.1822
Returns to GAAP Profitability, Achieves Record Cash Flow, Resumes Dividends & Strengthens Balance Sheet SOMERSET, N.J., March 13, 2025 (GLOBE NEWSWIRE) -- CareCloud, Inc. (NASDAQ:CCLD, CCLDO, CCLDP)), a leader in healthcare technology and generative AI solutions, today announced strong financial results for the full year ended December 31, 2024. The Company's strategic execution and AI-driven innovation have fueled a transformational turnaround, positioning CareCloud for continued profitability and long-term growth. CareCloud's management team will discuss these results and provide insights into 2025 growth strategies in a live conference call today at 8:30 a.m. ET. Full Year 2024 Perfor
SOMERSET, N.J., March 06, 2025 (GLOBE NEWSWIRE) -- CareCloud, Inc. (the "Company") (NASDAQ:CCLD, CCLDO, CCLDP)), a leader in healthcare information technology and generative AI solutions for medical practices and health systems nationwide, announced today (the "Mandatory Exchange Date") that it effected the mandatory conversion (the "Conversion") of shares of its 8.75% Series A Cumulative Redeemable Perpetual Preferred Stock (the "Preferred Stock"), into the Company's Common Stock, $0.001 par value per share (the "Common Stock"). "We are excited to announce this conversion, which will eliminate approximately $7 million or more in annual dividend obligations, freeing us to reinvest this ca
SOMERSET, N.J., Feb. 24, 2025 (GLOBE NEWSWIRE) -- CareCloud, Inc. (NASDAQ:CCLD, CCLDO, CCLDP)), a leader in healthcare technology and generative AI solutions for medical practices and health systems nationwide, will release its financial results for the fourth quarter and full year ended December 31, 2024 before the market opens on Thursday, March 13, 2025. The Company will follow with a conference call for investors at 8:30 a.m. Eastern Time. The live webcast of the conference call and related presentation slides can be accessed at ir.carecloud.com/events. An audio-only option is available by dialing 201-389-0920 and referencing "CareCloud Fourth Quarter 2024 Results Conference Call." In
SOMERSET, N.J., Feb. 13, 2025 (GLOBE NEWSWIRE) -- CareCloud, Inc. (NASDAQ:CCLD, CCLDO, CCLDP)), a leader in healthcare technology and generative AI solutions, today announced that it has transferred the funds for the January 2025 dividend payments on its Series A and Series B Cumulative Redeemable Perpetual Preferred Stock. As previously disclosed, holders of Series A Preferred Stock will receive 22.917 cents per share, while holders of Series B Preferred Stock will receive 18.229 cents per share based on a record date of January 31, 2025. These payments are expected to be reflected in shareholders' brokerage accounts between February 18 and February 20, 2025. "We appreciate the continue
Accelerated Timeline Reflects Strong Financial Performance and Commitment to Shareholder Value SOMERSET, N.J., Jan. 21, 2025 (GLOBE NEWSWIRE) -- CareCloud, Inc. (the "Company") (NASDAQ:CCLD, CCLDO, CCLDP)), a leader in healthcare information technology and generative AI solutions for medical practices and health systems nationwide, today announced that its Board of Directors (the "Board") has decided to resume dividend payments on its Series A Cumulative Redeemable Perpetual Preferred Stock (the "Series A Preferred Stock") and Series B Cumulative Redeemable Perpetual Preferred Stock (the "Series B Preferred Stock") earlier than previously announced based on the Company's success at accel
Pays Off Credit Line, Plans to Resume Preferred Dividends in Q1 2025 SOMERSET, N.J., Nov. 12, 2024 (GLOBE NEWSWIRE) -- CareCloud, Inc. (NASDAQ:CCLD, CCLDO, CCLDP)), a leader in healthcare technology and generative AI solutions for medical practices and health systems nationwide, announced financial and operational results for the quarter ended September 30, 2024 including that it has fully paid its credit line and that it plans to resume dividends on its Series A and B Preferred Stock on March 15, 2025. The Company's management will conduct a conference call with related slides today at 8:30 a.m. Eastern Time to discuss these results and management's outlook for the year.
SOMERSET, N.J., Oct. 24, 2024 (GLOBE NEWSWIRE) -- CareCloud, Inc. (NASDAQ:CCLD, CCLDO, CCLDP))), a leader in healthcare technology and generative AI solutions for medical practices and health systems nationwide, will release its financial results for the quarter ended September 30, 2024 before the market opens on Tuesday, November 12, 2024. The Company will follow with a conference call for investors at 8:30 a.m. Eastern Time. The live webcast of the conference call and related presentation slides can be accessed at ir.carecloud.com/events. An audio-only option is available by dialing 201-389-0920 and referencing "CareCloud Third Quarter 2024 Earnings Call." Investors who opt for audio-on
SOMERSET, N.J., Sept. 10, 2024 (GLOBE NEWSWIRE) -- CareCloud, Inc. (the "Company") (NASDAQ:CCLD, CCLDO, CCLDP))), a leader in healthcare technology solutions for medical practices and health systems nationwide, today announced that while proxy vote solicitation continues, it has already obtained approximately 99% of the minimum required "FOR" votes by proxy in support of the amendment to the Company's Certificate of Designations, Preferences and Rights of its Series A Preferred Stock (the "Preferred Stock Proposal"). As of today, the Company has supportive proxy indications from more than 2.97 million shares and believes that it is quickly approaching the required 3.02 million share thr
4 - CareCloud, Inc. (0001582982) (Issuer)
4 - CareCloud, Inc. (0001582982) (Issuer)
4 - CareCloud, Inc. (0001582982) (Issuer)
4 - CareCloud, Inc. (0001582982) (Issuer)
4 - CareCloud, Inc. (0001582982) (Issuer)
4 - CareCloud, Inc. (0001582982) (Issuer)
4 - CareCloud, Inc. (0001582982) (Issuer)
4 - CareCloud, Inc. (0001582982) (Issuer)
4 - CareCloud, Inc. (0001582982) (Issuer)
4 - CareCloud, Inc. (0001582982) (Issuer)
EFFECT - CareCloud, Inc. (0001582982) (Filer)
S-3 - CareCloud, Inc. (0001582982) (Filer)
DEFA14A - CareCloud, Inc. (0001582982) (Filer)
DEF 14A - CareCloud, Inc. (0001582982) (Filer)
10-K/A - CareCloud, Inc. (0001582982) (Filer)
25 - CareCloud, Inc. (0001582982) (Filer)
8-K - CareCloud, Inc. (0001582982) (Filer)
10-K - CareCloud, Inc. (0001582982) (Filer)
8-K - CareCloud, Inc. (0001582982) (Filer)
8-K - CareCloud, Inc. (0001582982) (Filer)
SOMERSET, N.J., April 17, 2025 (GLOBE NEWSWIRE) -- CareCloud, Inc. (NASDAQ:CCLD, CCLDO)), a leader in healthcare technology and generative AI solutions for medical practices and health systems nationwide, will release its financial results for the first quarter ended March 31, 2025 before the market opens on Tuesday, May 6, 2025. The Company will follow with a conference call for investors at 8:30 a.m. Eastern Time. The live webcast of the conference call and related presentation slides can be accessed at ir.carecloud.com/events. An audio-only option is available by dialing 201-389-0920 and referencing "CareCloud First Quarter 2025 Results Conference Call." Investors who opt for audio-onl
SOMERSET, N.J., April 07, 2025 (GLOBE NEWSWIRE) -- CareCloud, Inc. (the "Company") (NASDAQ:CCLD, CCLDO)), a leading provider of practice management, healthcare technology and AI-driven solutions to medical practices across the country, is pleased to announce its participation in the 15th Annual LD Micro Invitational at the Westin Grand Central Hotel in New York on April 9-10, 2025. The Company is scheduled to present on April 10, 2025 at 3:30 p.m. ET. CareCloud's management team will deliver a corporate presentation highlighting the Company's recent developments, innovative solutions, and strategic growth initiatives. Additionally, the team will participate in one-on-one meetings with ins
SOMERSET, N.J., April 02, 2025 (GLOBE NEWSWIRE) -- CareCloud, Inc. (the "Company") (NASDAQ:CCLD, CCLDO)), a leading provider of practice management, healthcare technology and AI-driven solutions to medical practices across the country, today announced the acquisition of RevNu Medical Management ("RevNu"), an emerging audiology-focused revenue cycle management ("RCM") company based in Westminster, California. "We've spent years building trusted relationships within the audiology community, and we couldn't be more excited to join forces with CareCloud," said Clay Gililland, founder of RevNu. "That experience has given us a deep understanding of the industry's needs—insights we're excited to
SOMERSET, N.J., March 26, 2025 (GLOBE NEWSWIRE) -- CareCloud, Inc. (the "Company") (NASDAQ:CCLD, CCLDO)), a leading provider of healthcare technology and AI-powered revenue cycle management (RCM) solutions, today announced the expanded adoption of its services by Alpine Ear, Nose & Throat PC, a premier otolaryngology group based in Colorado. Following a successful RCM engagement, Alpine ENT has now implemented CareCloud FrontDesk Assist—a comprehensive front-office solution designed to streamline operations and enhance patient satisfaction. "CareCloud has proven to be a true partner in optimizing our practice," said Mike Heck, CEO of Alpine ENT. "Since deploying FrontDesk Assist, we've se
SOMERSET, N.J., March 14, 2025 (GLOBE NEWSWIRE) -- CareCloud, Inc. (the "Company") (NASDAQ:CCLD, CCLDO, CCLDP)), a leader in healthcare technology and generative AI solutions for medical practices and health systems nationwide, announced today that its Board of Directors (the "Board") has declared monthly cash dividends for its 8.75% Series A Cumulative Redeemable Perpetual Preferred Stock ("Series A Preferred Stock") and its 8.75% Series B Cumulative Redeemable Perpetual Preferred Stock ("Series B Preferred Stock") for March and April 2025. The following table shows the monthly dividends and associated record and payment dates: March 2025 April 2025 Series A dividend per share $0.1822
Returns to GAAP Profitability, Achieves Record Cash Flow, Resumes Dividends & Strengthens Balance Sheet SOMERSET, N.J., March 13, 2025 (GLOBE NEWSWIRE) -- CareCloud, Inc. (NASDAQ:CCLD, CCLDO, CCLDP)), a leader in healthcare technology and generative AI solutions, today announced strong financial results for the full year ended December 31, 2024. The Company's strategic execution and AI-driven innovation have fueled a transformational turnaround, positioning CareCloud for continued profitability and long-term growth. CareCloud's management team will discuss these results and provide insights into 2025 growth strategies in a live conference call today at 8:30 a.m. ET. Full Year 2024 Perfor
SOMERSET, N.J., March 11, 2025 (GLOBE NEWSWIRE) -- CareCloud, Inc. (the "Company") (NASDAQ:CCLD, CCLDO, CCLDP)), a leader in healthcare information technology and generative AI solutions for medical practices and health systems nationwide, announced today that it will formally notify The Nasdaq Stock Market LLC of its intent to voluntarily delist its 8.75% Series A Cumulative Redeemable Perpetual Preferred Stock (NASDAQ:CCLDP) ("Series A Preferred Stock") from the Nasdaq Global Market. The Company expects to file a Form 25 with the Securities and Exchange Commission relating to the voluntary delisting of its Series A Preferred Stock on or about March 21, 2025, since the security no longer
SOMERSET, N.J., March 06, 2025 (GLOBE NEWSWIRE) -- CareCloud, Inc. (the "Company") (NASDAQ:CCLD, CCLDO, CCLDP)), a leader in healthcare information technology and generative AI solutions for medical practices and health systems nationwide, announced today (the "Mandatory Exchange Date") that it effected the mandatory conversion (the "Conversion") of shares of its 8.75% Series A Cumulative Redeemable Perpetual Preferred Stock (the "Preferred Stock"), into the Company's Common Stock, $0.001 par value per share (the "Common Stock"). "We are excited to announce this conversion, which will eliminate approximately $7 million or more in annual dividend obligations, freeing us to reinvest this ca
SOMERSET, N.J., March 03, 2025 (GLOBE NEWSWIRE) -- CareCloud, Inc. (the "Company") (NASDAQ:CCLD, CCLDO, CCLDP)), a leader in healthcare technology and AI-driven solutions, is back in acquisition mode— and ready to redefine the future of revenue cycle management. The Company today announced the successful acquisition of Mesa, LLC, d/b/a MesaBilling, marking its first deal in a renewed push for aggressive expansion. Finalized on February 28, 2025, this acquisition, though very small, sets the stage for a dynamic new era of strategic growth, reinforcing CareCloud's position at the forefront of the healthcare billing industry. "Partnering with CareCloud presents an incredible opportunity for
SOMERSET, N.J., Feb. 24, 2025 (GLOBE NEWSWIRE) -- CareCloud, Inc. (NASDAQ:CCLD, CCLDO, CCLDP)), a leader in healthcare technology and generative AI solutions for medical practices and health systems nationwide, will release its financial results for the fourth quarter and full year ended December 31, 2024 before the market opens on Thursday, March 13, 2025. The Company will follow with a conference call for investors at 8:30 a.m. Eastern Time. The live webcast of the conference call and related presentation slides can be accessed at ir.carecloud.com/events. An audio-only option is available by dialing 201-389-0920 and referencing "CareCloud Fourth Quarter 2024 Results Conference Call." In
ROTH MKM downgraded CareCloud from Buy to Neutral and set a new price target of $3.50 from $5.00 previously
SOMERSET, N.J., April 02, 2025 (GLOBE NEWSWIRE) -- CareCloud, Inc. (the "Company") (NASDAQ:CCLD, CCLDO)), a leading provider of practice management, healthcare technology and AI-driven solutions to medical practices across the country, today announced the acquisition of RevNu Medical Management ("RevNu"), an emerging audiology-focused revenue cycle management ("RCM") company based in Westminster, California. "We've spent years building trusted relationships within the audiology community, and we couldn't be more excited to join forces with CareCloud," said Clay Gililland, founder of RevNu. "That experience has given us a deep understanding of the industry's needs—insights we're excited to
SOMERSET, N.J., Dec. 04, 2023 (GLOBE NEWSWIRE) -- CareCloud, Inc. (NASDAQ:CCLD, CCLDP, CCLDO))), a leader in healthcare technology solutions for medical practices and health systems nationwide, today announced the appointment of Justin Pierce as its new chief sales officer (CSO). In this role, Pierce will be responsible for driving sustainable revenue growth and enhancing CareCloud's position in the rapidly evolving healthcare landscape. Pierce brings more than two decades of experience in the healthcare technology and services industry, having held leadership positions at Azalea Health, abeo, and Ventra Health. Throughout his career, he has consistently demonstrated his ability to forge
SOMERSET, N.J., July 11, 2023 (GLOBE NEWSWIRE) -- CareCloud, Inc. (NASDAQ:CCLD, CCLDP, CCLDO))), a leader in healthcare technology solutions for medical practices and health systems nationwide, today announced the appointment of Larry Steenvoorden as the new chief financial officer (CFO). With a distinguished career and extensive financial and strategic expertise, Steenvoorden brings valuable experience from his previous roles. Before joining CareCloud, he served as the executive vice president and CFO at Chembio Diagnostics, where he implemented strategic initiatives and improved profitability. Steenvoorden has also held CFO positions in healthcare, life science, and med-tech companies,
Bill Korn appointed chief strategy officer, Joseph DosSantos joins as chief financial officer, strengthening CareCloud's position as a leader in healthcare technology solutions. SOMERSET, N.J., May 08, 2023 (GLOBE NEWSWIRE) -- CareCloud, Inc. (NASDAQ:CCLD, CCLDP, CCLDO))), a leader in healthcare technology solutions for medical practices and health systems nationwide, announced today a leadership transition. Bill Korn, who has been CareCloud's chief financial officer (CFO) for 10 years, will take on a new role as chief strategy officer (CSO). The company has hired Joseph C. DosSantos, an experienced financial executive in the biotechnology sector, to fill the position of chief financial o